ACUMEN PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.18 USD | +0.32% |
|
+1.60% | -17.19% |
| 04/04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
| 04/04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Chart calendar Acumen Pharmaceuticals, Inc.
6d36d23def3066d6589ac0026ea4ca87.fxyxlPoci1uq7eUwn_HQchVUi57a4OIRURcbONci6pY.Kmrr4Iku5GvLtLx617iYB38D_fXut69yA31IDaZonuAITYbmsn25FOjVtA~0c7d7ba35a3b2732b3b4dc99a05a0abe
Upcoming events on Acumen Pharmaceuticals, Inc.
Past events on Acumen Pharmaceuticals, Inc.
| 17/04/2024 05:36 am | American Academy of Neurology Meeting |
| 17/04/2024 05:00 am | American Academy of Neurology Meeting |
| 26/03/2024 05:30 pm | Q4 2023 Earnings Call |
| 26/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 19/03/2024 09:30 pm | Stifel Virtual CNS Conference |
| 12/01/2024 12:00 am | JPMorgan Healthcare Conference |
| 15/11/2023 12:55 am | Stifel Healthcare Conference |
| 13/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 13/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 09/11/2023 08:30 pm | UBS BioPharma Conference |
| 27/10/2023 06:55 pm | Alzheimer Disease Clinical Trials Conference - Diana Kerwin |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Poster #LP 008 |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Poster #P003 |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Poster #LP 034 |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Mirjam Trame |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Eric Siemers |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Poster #LP 033 |
| 24/10/2023 | Alzheimer Disease Clinical Trials Conference - Stephen Salloway |
| 26/09/2023 06:50 pm | Cantor Global Healthcare Conference |
| 13/09/2023 08:00 pm | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -19,6 -15,5 -26.32% | -45,2 -40,4 -11.91% | -61,1 -57,0 -7.22% | -75,0 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -19,6 -16,9 -15.67% | -45,2 -41,3 -9.6% | -61,1 -58,7 -4.07% | -77,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -101 -98,8 -1.83% | -42,9 -41,0 -4.42% | -52,4 -51,2 -2.33% | -77,8 |
|
Net income Million USD | Released Forecast Spread | -7,33 | -101 -97,6 -3.12% | -42,9 -41,0 -4.5% | -52,4 -51,3 -2.15% | -68,6 |
|
EPS USD | Released Forecast Spread | -11,7 | -5,02 -3,46 -44.92% | -1,06 -0,98 -8.67% | -1,08 -1,04 -3.78% | -1,22 |
| Announcement Date | 12/04/21 | 28/03/22 | 27/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -18,5 -18,4 -0.34% | -16,1 | -17,0 | -19,9 | -22,0 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -8,42 -6,57 -28.18% | -9,21 -7,40 -24.41% | -10,4 -10,3 -0.86% | -11,4 -11,2 -1.88% | -14,2 -11,7 -21.45% | -13,1 -14,2 7.65% | -13,5 -14,6 7.92% | -16,0 -14,7 -9.02% | -18,5 -17,3 -7.11% | -16,7 | -17,3 | -19,2 | -20,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,35 -8,30 -0.59% | -10,2 -9,95 -1.99% | -10,7 -11,1 3.32% | -12,9 -12,1 -6.37% | -11,3 -14,5 22.02% | -11,6 -14,5 19.67% | -13,0 -14,5 10.87% | -16,5 -15,3 -7.84% | -10,3 | -11,1 | -12,4 | -13,9 | |
|
Net income Million USD | Released Forecast Spread | -8,35 -8,30 -0.59% | -10,2 -9,81 -3.5% | -10,7 -11,1 3.32% | -12,9 -11,5 -11.61% | -11,3 -14,0 19.4% | -11,6 -14,0 17.1% | -13,0 -14,2 8.69% | -16,5 -15,4 -7.19% | -15,5 | -16,6 | -17,9 | -18,6 | |
|
EPS USD | Released Forecast Spread | 1,98 -0,15 1425.83% | -0,23 -0,17 -35.29% | -0,25 -0,25 -1.35% | -0,26 -0,23 -12.61% | -0,32 -0,25 -28.86% | -0,28 -0,35 18.84% | -0,28 -0,35 19.08% | -0,24 -0,27 9.72% | -0,29 -0,27 -8.35% | -0,27 | -0,29 | -0,32 | -0,34 |
| Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 27/03/23 | 09/05/23 | 08/08/23 | 13/11/23 | 26/03/24 | - | - | - | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Acumen Pharmaceuticals, Inc.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 01:31 am | MORPHOSYS AG: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 28/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABOS Stock
- Calendar Acumen Pharmaceuticals, Inc.
